Stockreport

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardi [Read more]